Literature DB >> 12707386

Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis.

Kazutomo Sawai1, Kiyoshi Mori, Masashi Mukoyama, Akira Sugawara, Takayoshi Suganami, Masao Koshikawa, Kensei Yahata, Hisashi Makino, Tetsuya Nagae, Yuriko Fujinaga, Hideki Yokoi, Tetsuro Yoshioka, Akihiro Yoshimoto, Issei Tanaka, Kazuwa Nakao.   

Abstract

Dynamic recovery of glomerular structure occurs after severe glomerular damage in anti-Thy-1 glomerulonephritis (Thy-1 GN), but its mechanism remains to be investigated. To identify candidate genes possibly involved in glomerular reconstruction, screening was performed for genes that are specifically expressed by podocytes and are upregulated in glomeruli of Thy-1 GN. Among them, cysteine-rich protein 61 (Cyr61 or CCN1), a soluble angiogenic protein belonging to the CCN family, was identified. By Northern blot analysis, Cyr61 mRNA was markedly upregulated in glomeruli of Thy-1 GN from day 3 through day 7, when mesangial cell migration was most prominent. By in situ hybridization and immunohistochemistry, Cyr61 mRNA and protein were expressed by proximal straight tubules and afferent and efferent arterioles in normal rat kidneys and were intensely upregulated at podocytes in Thy-1 GN. Platelet-derived growth factor-BB (PDGF-BB) and transforming growth factor-beta1 (TGF-beta1), of which the gene expression in the glomeruli of Thy-1 GN was upregulated in similar time course as Cyr61, induced Cyr61 mRNA expression in cultured podocytes. Furthermore, supernatant of Cyr61-overexpressing cells inhibited PDGF-induced mesangial cell migration. In conclusion, it is shown that Cyr61 is strongly upregulated at podocytes in Thy-1 GN possibly by PDGF and TGF-beta. Cyr61 may be involved in glomerular remodeling as a factor secreted from podocytes to inhibit mesangial cell migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707386     DOI: 10.1097/01.asn.0000060576.61218.3d

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Searching for novel intercellular signal-transducing molecules in the kidney and their clinical application.

Authors:  Kiyoshi Mori; Masashi Mukoyama; Kazuwa Nakao
Journal:  Clin Exp Nephrol       Date:  2010-07-23       Impact factor: 2.801

Review 2.  Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.

Authors:  Hiroshi Kawachi; Koichi Suzuki; Naoko Miyauchi; Taeko Hashimoto; Yasuhiro Otaki; Fujio Shimizu
Journal:  Clin Exp Nephrol       Date:  2009-03-07       Impact factor: 2.801

Review 3.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

4.  Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.

Authors:  Takaya Handa; Keita P Mori; Akira Ishii; Shoko Ohno; Yugo Kanai; Haruko Watanabe-Takano; Akihiro Yasoda; Takashige Kuwabara; Nobuyuki Takahashi; Naoki Mochizuki; Masashi Mukoyama; Motoko Yanagita; Hideki Yokoi
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

Review 5.  Endothelial Progenitor Cell-Derived Extracellular Vesicles: Potential Therapeutic Application in Tissue Repair and Regeneration.

Authors:  Sonia Terriaca; Elena Fiorelli; Maria Giovanna Scioli; Giulia Fabbri; Gabriele Storti; Valerio Cervelli; Augusto Orlandi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

6.  Cysteine-rich protein 61 plays a proinflammatory role in obstructive kidney fibrosis.

Authors:  Chun-Fu Lai; Yung-Ming Chen; Wen-Chih Chiang; Shuei-Liong Lin; Min-Liang Kuo; Tun-Jun Tsai
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.